Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes, 22/November/2018, 10.56 pm

The tiny probiotic Bacillus clausii  may function as a Pain medication:  Probiotic Bacillus clausii increases the expression of PD-L1, attenuates acute and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability, via up-regulation of its target gene, 21/November/2018, 12.01 am
November 20, 2018
MANF-inducing compounds may protect you against stroke: MANF (Mesencephalic astrocyte-derived neurotrophic factor) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits, via up-regulation of its target genes BDNF and NAMPT, 23/November/2018, 6.20 am
November 23, 2018
Show all

Introduction: What they say

A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center for the Biology of Aging, Stanford University School of Medicine, Stanford, California 94305, USA Neuroscience Graduate Program, Stanford University School of Medicine, Stanford, California 94305, USA; Center for Tissue Regeneration, Repair and Restoration, V.A. Palo Alto Healthcare System, Palo Alto, California 94304, USA shows that “Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.” This research paper was published, in the 19 April 2017 issue of the journal “Nature” [One of the best research journals in General sciences with an I.F of 43+], by Prof.Tony Wyss-Coray, Joseph M. Castellano and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes

Figure1. Mechanistic insights into how the anesthetic agent Hyoscine may diminish learning, memory, and cognition. Hyoscine, by decreasing the expression of TIMP2, it decreases learning and memory in aged individuals.

Figure 2. John B. (Iain) Glen, who won the 2018 Lasker Clinical Medical Research Award (America’s Nobel), discovered the anesthetic agent Propofol. Anesthetic agent Hyoscine, by increasing the expression of its target genes, it may attenuate TIMB2 and BDNF expression. And thereby, it may attenuate learning, memory, and cognition

Figure 3. Anesthetic agent Hyoscine compromises learning, memory, and cognition through down-regulation of TIMB2 and BDNF


What is known?

Prof.Tony Wyss-Coray’s research team has recently shown that:  (1) human cord plasma treatment promotes cognitive and learning function in aged mice; (2) blood-borne component Tissue inhibitor of metalloproteinases 2 (TIMP2) is enriched in human cord plasma, young mouse plasma, and young mouse hippocampi; (3) TIMP2 increases hippocampal-dependent cognition; and (4) treating brain slices with TIMP2 antibody inhibits long-term potentiation and prevents hippocampal function, suggesting that increasing the expression of TIMP2 in aged individuals may enhance learning and memory.


 

From Research findings to Therapeutic opportunity:

A number of studies suggest that anesthetic agent Hyoscine may compromise cognition,  memory, and learning. However, the mechanism of action is far from clear. This study provides mechanistic insights into how repeated and the prolonged use of anesthetic agent Hyoscine may compromise cognition,  memory, and learning. Hyoscine, by increasing the expression of its target genes, may decrease the levels of TIMP2 and BDNF. Thereby, it may: (1) attenuate cognition and learning; (2) diminish spatial memory; and (3)  deteriorate hippocampal function (fig.1).


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How Hyoscine decreases the levels of TIMP2 and BDNF and attenuates memory and learning

Amount: $500#

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L.,  Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes, 22/November/2018, 10.56 pm, Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.